Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 3Graft vs Host Disease 2Stomatitis 1Myelodysplastic Syndromes 1Leukemia 1High Risk Myeloid Malignancies 1Carcinoma, Renal Cell 1Burkitt Lymphoma 1

Interventions

Fibroblast Growth Factor 7 9avasopasem manganese 4Low-Level Light Therapy 4Cisplatin 4Mouthwashes 3Control Groups 3Water 2Standard of Care 2Sodium Chloride 2Sodium Bicarbonate 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Propolis 2Laser Therapy 2Injections 2FGF20 protein, human 2Drug Therapy 2Chlorhexidine 2Benzydamine 2Ascorbic Acid 2whole grape extract 1sargramostim 1samital 1peppermint oil 1oxycodone-acetaminophen 1meclocycline 1golotimod 1dusquetide 1calcium phosphate 1brilacidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Stomatitis × Transplantation Conditioning × Clear all
NCT00189488 2014-09-15

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

Swedish Orphan Biovitrum

Phase 2 Completed
155 enrolled 19 charts
Other hematologic neoplasm

Graft vs Host Disease, Stomatitis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡